MECP2 and neurodegenerative disease: The work presents the ability of MeCP2 to enhance synaptic plasticity and indicates that strategies designed to maintain or elevate MeCP2 may be beneficial to the treatment of age‐related cognitive decline in neurodegenerative diseases.